These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13271439)

  • 1. The tyrosine oxidation system of liver. II. Oxidation of p-hydroxyphenylpyruvic acid to homogentisic acid.
    LA DU BN; ZANNONI VG
    J Biol Chem; 1955 Dec; 217(2):777-87. PubMed ID: 13271439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fermentative oxidation of rho-hydroxyphenylpyruvic acid to homogentisic acid].
    ROKA L; KONIG G; RUBNER H
    Hoppe Seylers Z Physiol Chem; 1958; 313():87-96. PubMed ID: 13620224
    [No Abstract]   [Full Text] [Related]  

  • 3. The tyrosine oxidation system of liver. III. Further studies on the oxidation of p-hydroxyphenylpyruvic acid.
    LA DU BN; ZANNONI VG
    J Biol Chem; 1956 Mar; 219(1):273-81. PubMed ID: 13295279
    [No Abstract]   [Full Text] [Related]  

  • 4. The oxidation in liver of l-tyrosine to acetoacetate through p-hydroxyphenylpyruvate and homogentisic acid.
    KNOX WE; LeMAY-KNOX M
    Biochem J; 1951 Oct; 49(5):686-93. PubMed ID: 14886367
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonenzymic oxidation of p-hydroxyphenylpyruvic acid with singlet oxygen to homogentisic acid. A model for the action of p-hydroxyphenylpyruvate hydroxylase.
    Saito I; Chujo Y; Shimazu H; Yamane M; Matsuura T
    J Am Chem Soc; 1975 Sep; 97(18):5272-7. PubMed ID: 1165361
    [No Abstract]   [Full Text] [Related]  

  • 6. The tyrosine oxidation system of liver. IV. Studies on the inhibition of p-hydroxyphenylpyruvic acid oxidase by excess substrate.
    ZANNONI VG; LA DU BN
    J Biol Chem; 1959 Nov; 234():2925-31. PubMed ID: 13846993
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of p-hydroxyphenylpyruvic acid into homogentisic acid: possible participation of p-quinol intermediates.
    Schweizer J; Lattrell R; Hecker E
    Experientia; 1975 Nov; 31(11):1267-8. PubMed ID: 1204767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A requirement for catalase in tyrosine metabolism: the oxidation of p-hydroxyphenylpyruvic acid to homogentisic acid.
    LA DU BN; ZANNONI VG
    Nature; 1956 Mar; 177(4508):574-5. PubMed ID: 13321906
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition and activation of the oxidation of homogentisic acid.
    SCHEPARTZ B
    J Biol Chem; 1953 Nov; 205(1):185-92. PubMed ID: 13117896
    [No Abstract]   [Full Text] [Related]  

  • 10. The Sulphation of p-hydroxyphenylpyruvic acid and related compounds by the rat liver cytosol.
    Hext PM; Rose FA
    Biochem J; 1975 Aug; 150(2):175-81. PubMed ID: 1180912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine metabolism in cirrhosis.
    Nordlinger BM; Fulenwider JT; Ivey GL; Faraj BA; Ali FM; Kutner M; Henderson JM; Rudman D
    J Lab Clin Med; 1979 Dec; 94(6):832-40. PubMed ID: 501206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxidative catabolism of tyrosine in vitiligo].
    Kurbanov Kh; Berezov TT
    Vopr Med Khim; 1974; 20(4):379-82. PubMed ID: 4156814
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic hypoxia: accumulation of tyrosine metabolites in hepatocytes at low pO2.
    Jones DP; Mason HS
    Biochem Biophys Res Commun; 1978 Feb; 80(3):477-83. PubMed ID: 24444
    [No Abstract]   [Full Text] [Related]  

  • 14. Aromatic biosynthesis. XVI. Aromatization of prephenic acid to p-hydroxyphenylpyruvic acid, a step in tyrosine biosynthesis in Escherichia coli.
    SCHWINCK I; ADAMS E
    Biochim Biophys Acta; 1959 Nov; 36():102-17. PubMed ID: 14444151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specificity of tyrosine metabolism depending on the state of melaninogenesis].
    Kurbanov Kh; Berezov TT
    Biull Eksp Biol Med; 1975 Aug; 80(8):44-7. PubMed ID: 241442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigation of aromatic acids in phenylketonuria, alkaptonuria and tyrosinosis using gas-liquid chromatography.
    Hill A; Hoag GN; Zaleski WA
    Clin Chim Acta; 1972 Mar; 37():455-62. PubMed ID: 5022110
    [No Abstract]   [Full Text] [Related]  

  • 17. Tyrosine metabolism in cirrhosis: acquired alkaptonuria.
    Nordlinger BM; Fulenwider JT; Faraj BA; Bethel RA; Rudman D
    Surg Forum; 1978; 29():442-4. PubMed ID: 401217
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dietary protein content and glucagon administration on tyrosine metabolism and tyrosine toxicity in the rat.
    Ip CC; Harper AE
    J Nutr; 1973 Nov; 103(11):1594-607. PubMed ID: 4148059
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion of tyrosine to phenolic derivatives by Taiwan cobra venom.
    Nucaro E; Jodra M; Russell E; Anderson L; Dennison P; Dufton M
    Toxicon; 1998 Aug; 36(8):1173-87. PubMed ID: 9690784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosyluria resulting from inhibition of p-hydroxyphenylpyruvic acid oxidase in vitamin C-deficient guinea pigs.
    ZANNONI VG; LA DU BN
    J Biol Chem; 1960 Sep; 235():2667-71. PubMed ID: 13846994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.